- Home
- Publications
- Publication Search
- Publication Details
Title
Mediators of Inflammation in Topical Therapy of Skin Cancers
Authors
Keywords
-
Journal
MEDIATORS OF INFLAMMATION
Volume 2019, Issue -, Pages 1-15
Publisher
Hindawi Limited
Online
2019-01-11
DOI
10.1155/2019/8369690
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neuroendocrine Factors and Head and Neck Squamous Cell Carcinoma: An Affair to Remember
- (2018) Iulia Solomon et al. DISEASE MARKERS
- Toll-like receptors in immunity and inflammatory diseases: Past, present, and future
- (2018) Kumar Vijay INTERNATIONAL IMMUNOPHARMACOLOGY
- A real-world, community-based cohort study comparing the effectiveness of topical fluorouracil versus topical imiquimod for the treatment of actinic keratosis
- (2018) Romain Neugebauer et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Surgery Versus 5% Imiquimod for Nodular and Superficial Basal Cell Carcinoma: 5-Year Results of the SINS Randomized Controlled Trial
- (2017) Hywel C. Williams et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Towards therapeutic advances in melanoma management: An overview
- (2017) Swarnendra Singh et al. LIFE SCIENCES
- The TLR7 agonist imiquimod induces anti-cancer effects via autophagic cell death and enhances anti-tumoral and systemic immunity during radiotherapy for melanoma
- (2017) Jeong Hyun Cho et al. Oncotarget
- Protocol for the TIDAL Melanoma Study: topical imiquimod or diphenylcyclopropenone for the management of cutaneous in-transit melanoma metastases—a phase II, single centre, randomised, pilot study
- (2017) Tavis Read et al. BMJ Open
- Dermoscopic monitoring of efficacy of ingenol mebutate in the treatment of pigmented and non-pigmented basal cell carcinomas
- (2016) Laura Diluvio et al. Dermatologic Therapy
- Gene Expression and Proteome Analysis as Sources of Biomarkers in Basal Cell Carcinoma
- (2016) Mihai Lupu et al. DISEASE MARKERS
- Proteomic Approaches to Biomarker Discovery in Cutaneous T-Cell Lymphoma
- (2016) Alexandra Ion et al. DISEASE MARKERS
- From Normal Skin to Squamous Cell Carcinoma: A Quest for Novel Biomarkers
- (2016) Vlad Voiculescu et al. DISEASE MARKERS
- Non-genetic risk factors for cutaneous melanoma and keratinocyte skin cancers: An umbrella review of meta-analyses
- (2016) Lazaros Belbasis et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Three-Year Follow-Up Results of Photodynamic Therapy vs. Imiquimod vs. Fluorouracil for Treatment of Superficial Basal Cell Carcinoma: A Single-Blind, Noninferiority, Randomized Controlled Trial
- (2016) Marieke H. Roozeboom et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Plaque/patch stage mycosis fungoides successfully treated with ingenol mebutate
- (2016) JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Chemically induced skin carcinogenesis: Updates in experimental models (Review)
- (2016) MONICA NEAGU et al. ONCOLOGY REPORTS
- Repeated Treatments with Ingenol Mebutate Prevents Progression of UV-Induced Photodamage in Hairless Mice
- (2016) Andrés Már Erlendsson et al. PLoS One
- Incidence and prevalence of non-melanoma skin cancer in Australia: A systematic review
- (2015) Eshini Perera et al. AUSTRALASIAN JOURNAL OF DERMATOLOGY
- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- An overview of the medical management of nonmelanoma skin cancer
- (2015) Lauren Metterle et al. CURRENT PROBLEMS IN CANCER
- Topical therapies for skin cancer and actinic keratosis
- (2015) Tasnuva Haque et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Tumor thickness and adnexal extension of superficial basal cell carcinoma (sBCC) as determinants of treatment failure for methylaminolevulinate (MAL)-photodynamic therapy (PDT), imiquimod, and 5-fluorouracil (FU)
- (2015) Marieke H. Roozeboom et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Oral keratinocyte stem/progenitor cells: specific markers, molecular signaling pathways and potential uses
- (2015) Bogdan Calenic et al. PERIODONTOLOGY 2000
- Skin Cancers as Contraindication to Organ Transplantation
- (2015) B. Imko-Walczuk et al. TRANSPLANTATION PROCEEDINGS
- Human papillomaviruses: shared and distinct pathways for pathogenesis
- (2015) Denise A Galloway et al. Current Opinion in Virology
- Catecholamines Increase in Vitro Proliferation of Murine B16F10 Melanoma Cells
- (2014) C Caruntu Acta Endocrinologica-Bucharest
- Basal Cell Carcinoma: An Evidence-Based Treatment Update
- (2014) Charlotte M. Clark et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Burden of disease caused by keratinocyte cancer has increased in The Netherlands since 1989
- (2014) Loes M. Hollestein et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Topical pharmacotherapy for skin cancer
- (2014) Giuseppe Micali et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Photodynamic therapy in the treatment of basal cell carcinoma: a systematic review and meta-analysis
- (2014) Hongfei Wang et al. PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE
- Hydrogel-Forming Microneedles Prepared from “Super Swelling” Polymers Combined with Lyophilised Wafers for Transdermal Drug Delivery
- (2014) Ryan F. Donnelly et al. PLoS One
- Visualization and Treatment of Subclinical Actinic Keratoses with Topical Imiquimod 5% Cream: An Observational Study
- (2014) Daisy Kopera et al. Biomed Research International
- Network meta-analysis of the outcome ‘participant complete clearance’ in nonimmunosuppressed participants of eight interventions for actinic keratosis: a follow-up on a Cochrane review
- (2013) A.K. Gupta et al. BRITISH JOURNAL OF DERMATOLOGY
- Non-melanoma skin cancers: Photodynamic therapy, cryotherapy, 5-fluorouracil, imiquimod, diclofenac, or what? Facts and controversies
- (2013) Jennifer D. Bahner et al. CLINICS IN DERMATOLOGY
- Toll-like receptors as therapeutic targets for cancer
- (2013) Johanna Holldack DRUG DISCOVERY TODAY
- Pharmacodynamics of ingenol mebutate 0.05% gel for the treatment of actinic keratosis assessed by histology
- (2013) JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial
- (2013) Aimée HMM Arits et al. LANCET ONCOLOGY
- Non-adherence to topical treatments for actinic keratosis
- (2013) Alison Carr et al. Patient Preference and Adherence
- Long-term Follow-up Study of Ingenol Mebutate Gel for the Treatment of Actinic Keratoses
- (2013) Mark Lebwohl et al. JAMA Dermatology
- Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells
- (2012) Barbara Drobits et al. JOURNAL OF CLINICAL INVESTIGATION
- Combined Intralesional Bacille Calmette-Guérin (BCG) and Topical Imiquimod for In-transit Melanoma
- (2012) Travis B. Kidner et al. JOURNAL OF IMMUNOTHERAPY
- The incidence of metastasis from cutaneous squamous cell carcinoma and the impact of its risk factors
- (2012) Nicholas D.L.S. Brougham et al. JOURNAL OF SURGICAL ONCOLOGY
- Ingenol Mebutate Gel for Actinic Keratosis
- (2012) Mark Lebwohl et al. NEW ENGLAND JOURNAL OF MEDICINE
- TLR signaling in mast cells: common and unique features
- (2012) Hilary Sandig et al. Frontiers in Immunology
- Ingenol Mebutate Field-Directed Treatment of UVB-Damaged Skin Reduces Lesion Formation and Removes Mutant p53 Patches
- (2011) Sarah-Jane Cozzi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Dual mechanism of action of ingenol mebutate gel for topical treatment of actinic keratoses: Rapid lesion necrosis followed by lesion-specific immune response
- (2011) Robert H. Rosen et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Constitutive Aberrant Endogenous Interleukin-1 Facilitates Inflammation and Growth in Human Melanoma
- (2011) Y. Qin et al. MOLECULAR CANCER RESEARCH
- Non-surgical treatments of primary, non-melanoma eyelid malignancies: a review
- (2010) Ann P Murchison et al. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Innate immunity and cancer therapy
- (2010) Kouji Maruyama et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Mechanisms of action of topical 5-fluorouracil: Review and implications for the treatment of dermatological disorders
- (2010) Roger I. Ceilley JOURNAL OF DERMATOLOGICAL TREATMENT
- UV Exposure Boosts Transcutaneous Immunization and Improves Tumor Immunity: Cytotoxic T-Cell Priming through the Skin
- (2010) Pamela Stein et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Targeting Toll-like receptors: emerging therapeutics?
- (2010) Elizabeth J. Hennessy et al. NATURE REVIEWS DRUG DISCOVERY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- The role of mast cells in atrial natriuretic peptide-induced cutaneous inflammation
- (2010) Ok Hee Chai et al. REGULATORY PEPTIDES
- Topical Imiquimod or Fluorouracil Therapy for Basal and Squamous Cell Carcinoma
- (2009) W. Elliot Love et al. ARCHIVES OF DERMATOLOGY
- Effectiveness of 5-fluorouracil treatment for actinic keratosis - a systematic review of randomized controlled trials
- (2009) Deborah A. Askew et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Imiquimod Enhances IFN-γ Production and Effector Function of T Cells Infiltrating Human Squamous Cell Carcinomas of the Skin
- (2009) Susan J. Huang et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Randomized, double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosis
- (2009) Lawrence Anderson et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study
- (2009) Jedd D Wolchok et al. LANCET ONCOLOGY
- Ca2+ Signaling, Mitochondria and Cell Death
- (2008) Paolo Pinton et al. CURRENT MOLECULAR MEDICINE
- Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study
- (2008) Kay D Brantsch et al. LANCET ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More